Menopause and Women's Health Course

Lesson 1 • Female Endocrine System Overview

Covers the hypothalamic-pituitary-ovarian axis and its regulatory feedback loops. Provides the hormonal framework needed for all subsequent menopause content.

Lesson 2 • Androgens in Female Health

Addresses testosterone, DHEA, and androstenedione roles in women's physiology. Prepares learners to assess androgen-related symptoms during menopause.

Lesson 3 • Menstrual Cycle Physiology

Details follicular, ovulatory, and luteal phases with associated hormone fluctuations. Connects normal cycle function to the disruptions seen in perimenopause.

Lesson 4 • Ovarian Reserve and Aging

Explains follicle depletion, declining AMH, and rising FSH as women age. Establishes the biological basis for the menopausal transition.

Lesson 1 • Premature Ovarian Insufficiency

Distinguishes POI from natural menopause by etiology, diagnosis, and long-term health implications. Prepares clinicians to manage this distinct and high-risk condition.

Lesson 2 • Patient History and Staging Assessment

Teaches structured history-taking to accurately stage menopause and identify contributing factors. Integrates hormonal knowledge into practical clinical assessment skills.

Lesson 3 • Hormonal Changes During Transition

Tracks estradiol, FSH, LH, and progesterone trajectories across the menopausal transition. Links hormonal shifts to the emergence of specific symptoms.

Lesson 4 • Epidemiology and Age of Onset

Reviews global data on average age of menopause, ethnic variation, and factors influencing timing. Contextualizes individual patient presentations within population norms.

Lesson 1 • Mood Changes and Anxiety

Covers estrogen's role in serotonin and GABA modulation and its link to perimenopausal mood symptoms. Distinguishes menopause-related mood changes from clinical depression.

Lesson 2 • Validated Symptom Assessment Tools

Introduces the MRS, Greene Climacteric Scale, and MENQOL for standardized symptom measurement. Enables consistent tracking of treatment response across clinical encounters.

Lesson 3 • Cognitive Symptoms and Brain Fog

Reviews evidence on memory, attention, and processing speed changes during menopause. Equips clinicians to counsel patients and distinguish normal changes from pathology.

Lesson 4 • Pathophysiology of Hot Flashes

Explains the thermoregulatory dysfunction and central noradrenergic mechanisms driving hot flashes. Connects neuroscience to symptom presentation and treatment targets.

Lesson 1 • Urinary Symptoms and Pelvic Floor

Covers urgency, frequency, recurrent UTIs, and stress incontinence linked to estrogen deficiency. Integrates pelvic floor assessment into the menopausal health evaluation.

Lesson 2 • Genitourinary Syndrome of Menopause

Defines GSM, its vulvovaginal and urinary components, and the estrogen-dependent tissue changes involved. Establishes GSM as a chronic, progressive condition requiring active management.

Lesson 3 • Non-Hormonal and Hormonal GSM Treatments

Compares lubricants, moisturizers, local estrogen, ospemifene, and laser therapy for GSM management. Guides treatment selection based on symptom severity, patient preference, and safety profile.

Lesson 4 • Vaginal Atrophy Assessment

Teaches clinical examination findings, pH testing, and maturation index interpretation for vaginal atrophy. Connects objective findings to patient-reported symptom severity.

Lesson 1 • Bone Health and Osteoporosis

Covers accelerated bone resorption, fracture risk assessment, and DXA interpretation in postmenopausal women. Links estrogen deficiency to skeletal fragility and prevention strategies.

Lesson 2 • Metabolic Syndrome and Weight Changes

Addresses central adiposity, insulin resistance, and metabolic syndrome risk emerging after menopause. Prepares clinicians to counsel on lifestyle and pharmacological prevention.

Lesson 3 • Cardiovascular Risk After Menopause

Explains how estrogen loss accelerates atherosclerosis, dyslipidemia, and hypertension risk. Establishes menopause as a cardiovascular risk inflection point requiring proactive screening.

Lesson 4 • Risk Stratification and Screening Protocols

Integrates cardiovascular, skeletal, and metabolic risk factors into a unified patient risk profile. Enables systematic, evidence-based preventive care planning for postmenopausal women.

Lesson 1 • Monitoring and Duration of MHT

Establishes follow-up schedules, safety monitoring parameters, and criteria for MHT continuation or discontinuation. Supports long-term, safe management of patients on hormone therapy.

Lesson 2 • MHT Regimens and Dosing

Explains cyclic, sequential, and continuous combined regimens with appropriate dosing for each menopausal stage. Guides regimen selection based on uterine status and symptom profile.

Lesson 3 • Benefits and Risks of MHT

Synthesizes evidence on MHT benefits for symptoms, bone, and cardiovascular health against risks of breast cancer and VTE. Equips clinicians to present balanced, individualized risk-benefit analyses.

Lesson 4 • MHT Pharmacology and Formulations

Covers estrogen and progestogen types, delivery routes, and pharmacokinetic differences across MHT formulations. Provides the pharmacological foundation for individualized prescribing decisions.

Lesson 1 • Physical Activity and Exercise Therapy

Presents evidence for aerobic, resistance, and mind-body exercise in reducing vasomotor, skeletal, and metabolic symptoms. Guides exercise prescription tailored to menopausal health goals.

Lesson 2 • Non-Hormonal Pharmacological Options

Reviews SSRIs, SNRIs, gabapentin, clonidine, and fezolinetant for vasomotor symptom management. Compares efficacy, side effects, and patient suitability for each agent.

Lesson 3 • Mind-Body and Behavioral Interventions

Covers cognitive behavioral therapy, mindfulness, hypnotherapy, and relaxation techniques for menopause symptoms. Provides evidence-based behavioral tools to complement pharmacological management.

Lesson 4 • Phytoestrogens and Botanical Supplements

Evaluates isoflavones, black cohosh, and other botanicals for symptom relief with attention to evidence quality and safety. Enables informed counseling on supplement use and drug interactions.

Lesson 1 • Menopause in Women with Diabetes

Covers glycemic variability during menopause, MHT effects on insulin sensitivity, and medication adjustments. Enables integrated management of menopause and diabetes simultaneously.

Lesson 2 • Menopause with Cardiovascular Disease

Guides MHT and non-hormonal management in women with established cardiovascular disease or high cardiac risk. Applies timing hypothesis and route-of-delivery evidence to clinical decisions.

Lesson 3 • Transgender and Gender-Diverse Patients

Addresses menopause-equivalent experiences in transgender men and gender-diverse individuals on hormone therapy. Applies inclusive, affirming care principles to symptom assessment and management.

Lesson 4 • Menopause After Breast Cancer

Addresses symptom management options for breast cancer survivors where systemic estrogen is contraindicated. Balances oncological safety with quality-of-life needs using non-hormonal strategies.